Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
03 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-pharma-oncology-to-present-preliminary-clinical-data-evaluating-investigational-agent-tp-3654-at-the-64th-ash-annual-meeting--exposition-301667810.html
18 Jul 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-pharma-oncology-receives-orphan-drug-designation-for-dsp-0390-an-investigational-emopamil-binding-protein-ebp-inhibitor-for-the-treatment-of-brain-cancer-301587648.html
08 Apr 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-pharma-oncology-presents-new-data-from-investigational-pipeline-of-novel-cancer-therapeutics-at-aacr-annual-meeting-2022-301521150.html
14 Dec 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-provides-update-on-phase-3-wizard-201g-study-of-ombipepimut-s-emulsion-dsp-7888-in-patients-with-recurrent-or-progressive-glioblastoma-301444814.html
03 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-first-patient-dosed-in-phase-1-dose-expansion-study-of-tp-1287-in-patients-with-sarcoma-301414798.html
09 Feb 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-phase-3-canstem303c-study-of-napabucasin-fails-to-reach-primary-endpoints-in-patients-with-previously-treated-metastatic-colorectal-cancer-301224902.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?